Headquarters: South San Francisco, California, United States
Trade prices
Volume:
Market Cap:535.72M
Prev closed:21.73
Open:22.7
High:25.26
Low:22
52 week low:11.85
52 week high:42
Dividends:No Dividends
Next ER:November 16, 2022 After Market Closes
Top Stories (RAPT)
Company Profile
RAPT Therapeutics (formerly FLX Bio) is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
Talk about RAPT Therapeutics below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
